|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Ladenburg Thalmann on 2020-06-26. The analyst firm set a price target for 12.25 expecting WINT to rise to within 12 months (a possible 412.55% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $2.39 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Windtree Therapeutics.
There is no upcoming split for Windtree Therapeutics.